Remarkably, most of the non-responders had high FIB-4 scores, relatively low PLT count (thrombocytopenia can be a surrogate marker of portal hypertension), and high ALT and AST (see “Supplementary data” page 1). This evidence concerns the gene GPT and portal hypertension.